Improving response to radiation in bladder cancer

Bladder cancer is the 4th most common cancer in UK men, with 10,100 new UK cases of bladder cancer diagnosed annually.

The form of the disease which has not penetrated into the bladder muscle is highly curable, but once the tumour grows into the muscle, only half the patients survive long-term. As a result, many high-risk patients have their bladder removed, but this is overtreatment in many patients and has a significant impact on their quality of life.

Therefore, there is an urgent need to find non-surgical treatments to treat patients in this situation.

Pictured is Professor Anne Kiltie (Senior Clinical Group Leader/Honorary Consultant Clinical Oncologist Oxford) with her team.